Dr. Lal Pathlabs Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Lal Pathlabs Quarterly Results    (DRLP)

Here are the latest quarterly results of Dr. Lal Pathlabs. For more details, see the Dr. Lal Pathlabs financial fact sheet and Dr. Lal Pathlabs share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Lal Pathlabs Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m3,6563,2793,0172,6604,3194,5244,3106,066 
Other income Rs m148138120114129135135141 
Turnover Rs m3,8043,4173,1372,7744,4484,6594,4456,207 
Expenses Rs m2,5672,4562,4442,1773,0473,1363,0904,176 
Gross profit Rs m1,0898235734831,2721,3881,2201,890 
Depreciation Rs m177188200179195195203192 
Interest Rs m3739393740394446 
Profit before tax Rs m1,0237344543811,1661,2891,1081,793 
Tax Rs m21318512897295330257456 
Profit after tax Rs m8105493262848719598511,337 
Gross profit margin %29.825.119.018.229.530.728.331.2 
Effective tax rate %20.825.228.225.525.325.623.225.4 
Net profit margin %22.216.710.810.720.221.219.722.0 
Diluted EPS Rs 9.7 6.6 3.9 3.4 10.5 11.5 10.2 16.0  
Diluted EPS (TTM) Rs NA 29.1 27.3 23.6 24.4 29.3 35.6 48.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: Dr. Lal Pathlabs 1QFY22 Result Performance Review

More Hospital & Healthcare Services Company Quarterly Results:   BIOFIL CHEMICALS  ASTER DM HEALTHCARE  SWAGRUHA INFRA  DIVIS LABORATORIES  ARTEMIS MEDICARE SERVICES  

Compare DR. LAL PATHLABS With:   BIOFIL CHEMICALS  ASTER DM HEALTHCARE  SWAGRUHA INFRA  DIVIS LABORATORIES  ARTEMIS MEDICARE SERVICES  



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

DR. LAL PATHLABS Announces Quarterly Results (1QFY22); Net Profit Up 370.8% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, DR. LAL PATHLABS has posted a net profit of Rs 1 bn (up 370.8% YoY). Sales on the other hand came in at Rs 6 bn (up 128.0% YoY). Read on for a complete analysis of DR. LAL PATHLABS's quarterly results.

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

More Views on News

Most Popular

These Stocks Are Ready to Zoom (Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks (Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider (Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks (Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. LAL PATHLABS SHARE PRICE


Aug 5, 2021 (Close)

TRACK DR. LAL PATHLABS

  • Track your investment in DR. LAL PATHLABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. LAL PATHLABS

DR. LAL PATHLABS 5-YR ANALYSIS

COMPARE DR. LAL PATHLABS WITH

MARKET STATS